AIRLINK 202.36 Increased By ▲ 1.12 (0.56%)
BOP 10.16 Increased By ▲ 0.19 (1.91%)
CNERGY 7.17 Increased By ▲ 0.28 (4.06%)
FCCL 37.01 Increased By ▲ 1.65 (4.67%)
FFL 17.19 Increased By ▲ 0.04 (0.23%)
FLYNG 25.74 Increased By ▲ 1.53 (6.32%)
HUBC 135.40 Decreased By ▼ -2.79 (-2.02%)
HUMNL 14.10 Increased By ▲ 0.03 (0.21%)
KEL 4.85 Decreased By ▼ -0.01 (-0.21%)
KOSM 6.68 Increased By ▲ 0.02 (0.3%)
MLCF 46.30 Decreased By ▼ -0.01 (-0.02%)
OGDC 222.50 Decreased By ▼ -0.04 (-0.02%)
PACE 7.04 Decreased By ▼ -0.02 (-0.28%)
PAEL 42.35 Decreased By ▼ -0.79 (-1.83%)
PIAHCLA 17.05 Increased By ▲ 0.02 (0.12%)
PIBTL 8.59 Increased By ▲ 0.05 (0.59%)
POWER 9.65 Increased By ▲ 0.55 (6.04%)
PPL 188.45 Decreased By ▼ -0.31 (-0.16%)
PRL 42.52 Decreased By ▼ -0.75 (-1.73%)
PTC 25.30 Decreased By ▼ -0.05 (-0.2%)
SEARL 108.87 Decreased By ▼ -1.55 (-1.4%)
SILK 1.02 Decreased By ▼ -0.01 (-0.97%)
SSGC 42.45 Decreased By ▼ -0.19 (-0.45%)
SYM 18.46 Decreased By ▼ -0.11 (-0.59%)
TELE 9.06 Decreased By ▼ -0.06 (-0.66%)
TPLP 13.55 Decreased By ▼ -0.13 (-0.95%)
TRG 67.86 Decreased By ▼ -0.30 (-0.44%)
WAVESAPP 10.40 Increased By ▲ 0.13 (1.27%)
WTL 1.85 Decreased By ▼ -0.02 (-1.07%)
YOUW 4.04 Increased By ▲ 0.03 (0.75%)
BR100 12,257 Increased By 37 (0.3%)
BR30 37,254 Decreased By -63.3 (-0.17%)
KSE100 116,094 Increased By 249.3 (0.22%)
KSE30 36,581 Increased By 105.3 (0.29%)

WASHINGTON: US doctors announced Thursday they had successfully performed a double lung transplant on a patient with terminal lung cancer, giving new hope to others who also have advanced stages of the deadly disease.

Albert Khoury, a 54-year-old non-smoker, underwent a seven-hour surgery to receive his new lungs at Northwestern Medicine in Chicago on September 25, 2021.

Six months on, the lungs are working well and he has no signs of cancer in his body.

“Lung transplantation for lung cancer is extremely uncommon with few cases reported,” Ankit Bharat, chief of thoracic surgery at Northwestern Medicine, said in a statement.

“For patients with stage 4 cancer, lung transplantation is considered a complete ‘no-no,’ but because Albert’s cancer was confined only to his chest, we were confident we could clear all the cancer during surgery and save his life.” Surgeons are generally reluctant to proceed with such transplants because if there are even a few cancerous cells remaining, there is a strong chance they will regrow in a patient taking immune-suppressing medications to prevent organ rejection.

The few such procedures in the past have not been successful, but since then, advances have allowed doctors to better understand cancer’s spread.

Comments

Comments are closed.